Severe malignant osteopetrosis

Active Ingredient: Interferon gamma-1b

Indication for Interferon gamma-1b

Population group: only adults (18 - 65 years old)

Interferon gamma-1b is indicated for the reduction in frequency of serious infections in patients with severe, malignant osteopetrosis.

For this indication, competent medicine agencies globally authorize below treatments:

50 mcg/m²

Route of admnistration


Defined daily dose

50 - 50 ug per m² of body surface area (BSA)

Dosage regimen

From 50 To 50 ug per m² of body surface area (BSA) once every 2 day(s)

Detailed description

The recommended dosage of interferon gamma-1b for the treatment of patients with CGD or severe, malignant osteopetrosis is 50 mcg/m² for patients whose body surface area is greater than 0.5 m² and 1.5 mcg/kg/dose for patients whose body surface area is equal to or less than 0.5 m². The actually drawn volume has to be controlled before injection. Injections should be administered subcutaneously preferably in the evening three times weekly (for example, Monday, Wednesday, Friday). The optimum sites of injection are the right and the left deltoid and anterior thigh. Interferon gamma-1b can be administered by a physician, nurse, family member or patient when trained in the administration of subcutaneous injections.

Although the most beneficial dose of interferon gamma-1b is not known yet higher doses are not recommended. Safety and efficacy has not been established for interferon gamma-1b given in doses greater or less than the recommended dose of 50 mcg/m². If severe reactions occur, the dosage should be modified (50% reduction) or therapy should be discontinued until the adverse reaction abates.

Active ingredient

Interferon gamma-1b

It is presumed that interferon gamma-1b increases macrophage cytotoxicity by enhancing the respiratory burst via generation of toxic oxygen metabolites capable of mediating the killing of intracellular micro-organisms.

Read more about Interferon gamma-1b

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.